Literature DB >> 16384626

PIN1 promoter polymorphisms are associated with Alzheimer's disease.

L Segat1, A Pontillo, G Annoni, D Trabattoni, C Vergani, M Clerici, B Arosio, S Crovella.   

Abstract

In our study, we analyzed the coding and promoter regions of the PIN1 gene in a group of 111 Alzheimer's disease (AD) patients looking for a possible genotype-phenotype correlation. The presence of SNPs - which could affect and modify the clinical phenotype of AD patients was also investigated. We identified two single nucleotide polymorphisms (SNPs) at positions -842 (G-->C) and -667 (C-->T) in the promoter region of the PIN1 gene. Our results evidenced a significantly higher percentage of -842C allele carriers in AD subjects with respect to healthy controls. We found that this allele significantly raised the risk of developing AD (OR 3.044, CI 1.42-6.52). The -842 and -667 SNPs were in linkage disequilibrium and combined to form haplotypes. The CC haplotype conferred a higher risk of developing AD (OR 2.95, confidence interval 1.31-6.82). Finally, protein expression analyses revealed that subjects carrying the -842 CC genotype or the CC haplotype showed reduced levels of the PIN1 protein in peripheral mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16384626     DOI: 10.1016/j.neurobiolaging.2005.11.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  32 in total

1.  Prolyl isomerase Pin1 regulates neuronal differentiation via β-catenin.

Authors:  Kazuhiro Nakamura; Isao Kosugi; Daniel Y Lee; Angela Hafner; David A Sinclair; Akihide Ryo; Kun Ping Lu
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.

Authors:  Suk Ling Ma; Nelson Leung Sang Tang; Cindy Woon Chi Tam; Victor Wing Cheong Lui; Linda Chiu Wa Lam; Helen Fung Kum Chiu; Jane Ann Driver; Lucia Pastorino; Kun Ping Lu
Journal:  Neurobiol Aging       Date:  2010-06-30       Impact factor: 4.673

Review 3.  Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.

Authors:  Jane A Driver; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2015-01-10

Review 4.  Prolyl isomerases in gene transcription.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-10-31

Review 5.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

6.  Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.

Authors:  Yifeng Du; Michael C Wooten; Marla Gearing; Marie W Wooten
Journal:  Free Radic Biol Med       Date:  2008-11-21       Impact factor: 7.376

Review 7.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

8.  Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies.

Authors:  Kazuhiro Nakamura; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Prion       Date:  2012-11-15       Impact factor: 3.931

9.  A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity.

Authors:  Jiachun Lu; Zhibin Hu; Sheng Wei; Li-E Wang; Zhensheng Liu; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

10.  Genome scan in familial late-onset Alzheimer's disease: a locus on chromosome 6 contributes to age-at-onset.

Authors:  Wei Zhao; Elizabeth E Marchani; Charles Y K Cheung; Ellen J Steinbart; Gerard D Schellenberg; Thomas D Bird; Ellen M Wijsman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-01-25       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.